Skip to main content
. 2020 Apr 29;9(4):42. doi: 10.1038/s41389-020-0226-z

Table 1.

Clinicopathological correlation of ACSL4 expression in human HCC.

Variables Tumor ACSL4 expression
Low High p-valuea
Age
 ≤50 years 19 (47.5%) 21 (52.5%) 0.354
 >50 years 27 (57.4%) 20 (42.6%)
Gender
 Female 5 (62.5%) 3 (37.5%) 0.567
 Male 41 (51.9%) 38 (48.1%)
HBsAg status
 Negative 9 (52.9%) 8 (47.1%) 0.995
 Positive 37 (52.9%) 33 (47.1%)
Cirrhosis
 Absent 5 (55.6%) 4 (44.4%) 0.865
 Present 41 (52.6%) 37 (47.4%)
Tumor encapsulation
 Complete 20 (50%) 20 (50%) 0.620
 No complete 26 (55.3%) 21 (44.7%)
Tumor size
 ≤5 cm 29 (47.5%) 32 (52.5%) 0.127
 >5 cm 17 (65.4%) 9 (34.6%)
Tumor number
 Single 43 (55.8%) 34 (44.2%) 0.123
 Multiple 3 (30%) 7 (70%)
Edmondson–Steiner grade
 I–II 35 (54.7%) 26 (45.3%) 0.572
 III–IV 11 (47.8%) 12 (52.2%)
PVTT
 Absent 32 (50.8%) 31 (49.2%) 0.529
 Present 14 (58.3%) 10 (41.7%)
Alpha-fetoprotein level
 ≤20 ng/ml 25 (71.4%) 10 (28.6%) 0.030
 >400 ng/ml 14 (45.2%) 17 (54.8%)

ap-values were derived with a two-tailed Pearson chi-square test.